- Home
- SMJF vs RNAZ Comparison
SMJF vs RNAZ Comparison
Compare SMJF & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMJF | RNAZ |
|---|---|---|
| Founded | 1988 | 2016 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 27.9M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SMJF | RNAZ |
|---|---|---|
| Price | $1.54 | $1.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 684.7K | 45.5K |
| Earning Date | 11-08-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $68.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $1.52 |
| 52 Week High | $11.48 | $15.90 |
Technical Indicators
Market Signals| Indicator | SMJF | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 46.57 |
| Support Level | $0.91 | $1.83 |
| Resistance Level | $3.72 | $2.39 |
| Average True Range (ATR) | 0.44 | 0.20 |
| MACD | 0.16 | 0.11 |
| Stochastic Oscillator | 19.50 | 43.10 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, polypropylene tiles, broadloom carpets, and vinyl tiles. It operates under the proprietary brand 'SMJ'. The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. Geographically, it has a presence across Malaysia, Indonesia, the Philippines, Vietnam, India, Singapore, and other markets. The company generates revenue mainly through the sale and distribution of its flooring products, prominently in Singapore.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.